Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly improve patient outcomes for hypertension and other chronic conditions. If successful, Dynocardia's technology could ultimately enable widespread availability of continuous blood pressure monitoring and deeper clinical insights beyond current point-in-time cuff-based measurements. The one-year project period extends from March 1, 2022 to February 28, 2023.